Isaac Health said that it has joined the LillyDirect digital‐healthcare platform operated by Eli Lilly and Company in the U.S. to expand access to specialist care for individuals with memory- and thinking-concern symptoms linked to Alzheimer’s disease or related dementias. According to the company, being listed as a provider on the platform enables health-plan members and consumers to connect with its virtual and in-home clinic services.
The company said that its services include neuropsychological and neurological assessments, specialist consultations and in-home or virtual care management for cognitive decline and dementia. It claims that the partnership aims to shorten wait-times and improve reach into underserved and rural communities.
Isaac Health said that the collaboration aligns with LillyDirect’s aim of increasing provider capacity for dementia-care by connecting consumers to independent telehealth and in-person specialists. The company added that the listing on LillyDirect could accelerate early diagnosis and specialist intervention in memory disorders.
Under the agreement, consumers navigating LillyDirect will be able to access information about Isaac Health’s offerings and initiate referrals or consultations through the platform. The company said that the new listing is part of its broader strategy to scale specialist brain-health services nationally.
